Enquiry/Quote
Sorafenib bulk supplier for pharma manufacturers

Sorafenib Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 200 mg

Reference Brands: Nexavar (US & EU)

Category: Oncology Cancer Care

Sorafenib is an oral kinase inhibitor used to treat advanced liver cancer (HCC), renal cell carcinoma (RCC), and thyroid cancer. Available in 200 mg tablets under the brand Nexavarยฎ in the US and EU, it blocks tumor cell growth and angiogenesis. Ideal for B2B pharma distributors.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

๐Ÿ“˜ Sourcing Guide

Product Description:

Sorafenib is a targeted therapy used in the treatment of advanced liver cancer (HCC), renal cell carcinoma (RCC), and thyroid cancer. As an oral kinase inhibitor, it works by blocking tumor cell proliferation and angiogenesis. Available under the brand name Nexavar®, it is marketed in 200 mg tablets in both the US and EU. Sorafenib is a critical component in the treatment of various solid tumors and is manufactured under GMP-compliant standards. Ideal for B2B pharmaceutical partners, it is supplied globally for oncology distributors and hospital tender markets seeking reliable oncology treatments.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Sorafenib tosylate is used for the treatment of certain types of cancer, including hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma (kidney cancer), and radioactive iodine-refractory differentiated thyroid carcinoma. It works by slowing tumor cell growth and reducing tumor blood vessel formation.

Sorafenib is made from the active pharmaceutical ingredient sorafenib tosylate, a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis by targeting multiple intracellular and cell surface kinases.

The main international trade name is Nexavar.

The original branded product Nexavar is developed and marketed by Bayer. Generic sorafenib products are manufactured by multiple pharmaceutical companies worldwide after patent expiry in several regions.

The complete generic name is sorafenib tosylate.

The primary brand name is Nexavar.

Sorafenib tablets are manufactured in multiple countries including the USA, EU, UK, and India by Bayer and various GMP-certified generic manufacturers for global oncology supply.

Related Products

Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Idelalisib

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Zydelig (EU/UK/India)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.